Index of artpub/2024/302148/

Hess, Georg
Indirect treatment comparison of brexucabtagene autoleucel (ZUMA-2) versus standard of care (SCHOLAR-2) in relapsed/refractory mantle cell lymphoma
2024
https://ddd.uab.cat/record/302148